Format

Send to

Choose Destination
Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):412-420. doi: 10.1002/pds.4153. Epub 2017 Jan 4.

Identifying birth defects in automated data sources in the Vaccine Safety Datalink.

Author information

1
HealthPartners Institute, Minneapolis, MN, USA.
2
University of Iowa, Iowa City, IA, USA.
3
Center for Health Research Kaiser Permanente Northwest, Portland, OR, USA.
4
Kaiser Permanente Southern California, Los Angeles, CA, USA.
5
Yale University School of Medicine, New Haven, CT, USA.
6
University of Minnesota, Minneapolis, MN, USA.
7
Kaiser Permanente Northern California, San Francisco, CA, USA.
8
Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA.
9
Group Health Research Institute, Seattle, WA, USA.
10
Institute for Health Research, Kaiser Permanente Colorado and Ambulatory Care Services, Denver Health, Denver, CO, USA.
11
Centers for Disease Control and Prevention, Atlanta, GA, USA.

Abstract

PURPOSE:

The Vaccine Safety Datalink (VSD), a collaboration between the Centers for Disease Control and Prevention and several large healthcare organizations, aims to monitor safety of vaccines administered in the USA. We present definitions and prevalence estimates for major structural birth defects to be used in studies of maternal vaccine safety.

METHODS:

In this observational study, we created and refined algorithms for identifying major structural birth defects from electronic healthcare data, conducted formal chart reviews for severe cardiac defects, and conducted limited chart validation for other defects. We estimated prevalence for selected defects by VSD site and birth year and compared these estimates to those in a US and European surveillance system.

RESULTS:

We developed algorithms to enumerate >50 major structural birth defects from standardized administrative and healthcare data based on utilization patterns and expert opinion, applying criteria for number, timing, and setting of diagnoses. Our birth cohort included 497 894 infants across seven sites. The period prevalence for all selected major birth defects in the VSD from 2004 to 2013 was 1.7 per 100 live births. Cardiac defects were most common (65.4 per 10 000 live births), with one-fourth classified as severe, requiring emergent intervention. For most major structural birth defects, prevalence estimates were stable over time and across sites and similar to those reported in other population-based surveillance systems.

CONCLUSIONS:

Our algorithms can efficiently identify many major structural birth defects in large healthcare datasets and can be used in studies evaluating the safety of vaccines administered to pregnant women. Copyright © 2017 John Wiley & Sons, Ltd.

KEYWORDS:

congenital anomalies; electronic health data; pharmacoepidemiology; prevalence; validity

PMID:
28054412
DOI:
10.1002/pds.4153
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center